Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up taking into account A1C and the main cardiovascular risk factors. RESEARCH DESIGN AND METHODS: Consecutive type 2 diabetic patients (n = 505) followed up at our diabetes clinic were evaluated at baseline (1995) for the main cardiovascular risk factors and for five glycemic control parameters (fasting blood glucose, blood glucose 2 h after breakfast, blood glucose 2 h after lunch, blood glucose before dinner, and A1C); all-cause mortality and the first cardiovascular events occurring during the 14-year follow-up were measured. RESULTS: We observed 172 cardiovascular events (34.1% of the population) and 147 deaths (29.1% of the population). Using the Cox analysis with the backward method, we categorized the variables according to the therapeutic targets of the American Diabetes Association. Our observations were as follows. When the five glycemic control parameters were considered together, the predictors were 1) for cardiovascular events, blood glucose 2 h after lunch (hazard ratio 1.507, P = 0.010) and A1C (1.792, P = 0.002); and 2) for mortality, blood glucose 2 h after lunch (1.885, P < 0.0001) and A1C (1.907, P = 0.002). When blood glucose 2 h after lunch and A1C were considered together with the main cardiovascular risk factors, the following glycemic control parameters were predictors: 1) for cardiovascular events, blood glucose 2 h after lunch (1.452, P = 0.021) and A1C (1.732, P = 0.004); and 2) for mortality, blood glucose 2 h after lunch (1.846, P = 0.001) and A1C (1.896, P = 0.004). CONCLUSIONS: In type 2 diabetes, both postprandial blood glucose and A1C predict cardiovascular events and all-cause mortality in a long-term follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, elevated 2 h postprandial glucose levels have been associated with a 50% greater risk of cardiovascular events and an 89% increase in all‐cause mortality (Cavalot et al., 2011).”
From Acute systemic and energy metabolism responses to velocity-based resistance training following an oral glucose load in individuals with excess body weight (2026) · cites this paper as Cavalot et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 1×
“The specific contribution of FBG and postprandial blood glucose to A1C was considered in detail elsewhere (22,23); in our study, the correlation of these two variables with A1C is similar.”
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · cited 1×
“It has been shown that reduction of hyperglycemia prevents diabetes macrovascular disease; in particular, a metaanalysis of randomized controlled trials evaluating the effects on cardiovascular outcomes and mortality of intensive blood glucose control policies targeting A1C showed a beneficial effect on coronary event…”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874 · cited 3×
“Note also that all patients considered in that study were on hypoglycemic treatment (24): either combination oral regimen with a sulphonylurea plus metformin or insulin, with or without concomitant oral agents; thus, they were at hypoglycemic risk.”
InfluentialHanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873 · cited 13×
“Our study, therefore, confirms that which has been observed in the 11-year follow-up of the DIS concerning FBG (9).”
BackgroundResultInfluentialLevitan, E. B., Song, Y., Ford, E. S., & Liu, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2147 · Cited by 668 · cited 1×
“Furthermore, a meta-analysis of 38 prospective studies carried out in nondiabetic subjects confirmed a strong association between 2-h postchallenge blood glucose with fatal and nonfatal cardiovascular events (3), and a linear relationship between this parameter and the risk of cardiovascular death has been observed (4…”
BackgroundHanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641 · cited 1×
“The following evidence is available: 1) a meta-analysis of seven randomized controlled trials in type 2 diabetes indicates that acarbose, a drug that corrects postprandial hyperglycemia by impairing carbohydrate absorption, reduces the occurrence of cardiovascular events; this effect has also been described in patient…”
BackgroundCavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569 · cited 8×
“This kind of categorization was the same as that used in the 5-year follow-up (10).”
BackgroundMethodResultInfluentialSelf-citationFasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Cited by
Items 201–300 of 322
The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes
Riceman, M. D., Bound, M. J., Grivell, J., Hatzinikolas, S., Piotto, S., Nguyen, N. Q., Jones, K. L., Horowitz, M., Rayner, C. K., & Phillips, L. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107822 · Cited by 7
Pulbutr, P., Nantana, P., Suksabai, S., Mudjupa, C., Denchai, R., Rattanakiat, S., & Dhammaraj, T. (2020) · Pharmacognosy Research · doi:10.4103/pr.pr_117_19 · Cited by 8
Usui, M., Tanaka, M., & Takahashi, H. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100233 · Cited by 7
Huang, Z., Chen, K., Li, T., He, X., Ge, X., Liu, X., Liu, B., & Zeng, F. (2024) · eFood · doi:10.1002/efd2.70007 · Cited by 10
Yuan, T., Yu, W., & Chen, Y. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105562 · Cited by 8
Brown, J. E., Pham, T., Burden, H. J., & Braakhuis, A. J. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.102018 · Cited by 8
“[12], liver cirrhosis [17], obesity [7], and enhanced all-cause mortality in both type 2 diabetes [9] and cancer [18].”
BackgroundNakayama, Y., Ono, K., Okagawa, J., Urabe, J., Yamau, R., & Ishikawa, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074227 · Cited by 8
Russo, I., Viretto, M., Doronzo, G., Barale, C., Mattiello, L., Anfossi, G., & Trovati, M. (2014) · BioMed Research International · doi:10.1155/2014/328959 · Cited by 6
“Interestingly, in a prospective study carried out in our diabetes clinic, we demonstrated that postprandial blood glucose is a stronger predictor of cardiovascular events and death than fasting blood glucose even after the correction for the long-term glucose control marker haemoglobin A1C [27, 28].”
BackgroundSelf-citationKataoka, Y., Hosoda, K., Makino, H., Matsubara, M., Matsuo, M., Ohata, Y., Koezuka, R., Tamanaha, T., Tomita, T., Honda-Kohmo, K., et al. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.09.02 · Cited by 6
Indarto, D., Rochmah, D. N., Wiboworini, B., Pratama, Y. M., & Wibowo, Y. C. (2022) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_704_20 · Cited by 7
Gal, D. (2016) · Journal of the Association for Consumer Research · doi:10.1086/684395 · Cited by 7
Harnessing the gut microbiota to promote metabolic health
Zmora, N. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa076 · Cited by 5
Peschard, S., Raverdy, V., Bauvin, P., Goutchtat, R., Touche, V., Derudas, B., Gheeraert, C., Dubois‐Chevalier, J., Caiazzo, R. J., Baud, G., et al. (2024) · Diabetes · doi:10.2337/db23-0805 · Cited by 5
Mora‐Rodríguez, R., Moreno‐Cabañas, A., Álvarez-Jiménez, L., Mora‐Gonzalez, D., ORTEGA, J. F., & Morales‐Palomo, F. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2023 · Cited by 5
Tsaban, G., Aharon‐Hananel, G., Shalem, S., Zelicha, H., Meir, A. Y., Pachter, D., Goldberg, D. T., Kamer, O., Alufer, L., Stampfer, M. J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15840 · Cited by 7
Wang, X., Fan, F., Jia, J., Xu, X. P., Qin, X., Zheng, B., Li, H., Li, D., Wang, S. Y., Li, J. P., et al. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s167233 · Cited by 5
“19 Meanwhile, postprandial plasma glucose was found to be related to CKD in an earlier study.”
Glycemic Key Metrics and the Risk of Diabetes-Associated Complications
Kohnert, K., Heinke, P., Zander, E., Vogt, L., & Salzsieder, E. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0047 · Cited by 5
“2011 [14] Glycemic variability Microvascular disease Kilpatrick et al.”
BackgroundHeller, S. R., Meneghini, L., Nikolajsen, A., Kragh, N., Lewis, H. B., Saretsky, T. L., Kosmas, C. E., & Lloyd, A. J. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1525344 · Cited by 5
Ahmad, A., Lim, L., Morieri, M. L., Tam, C., Cheng, F., Chikowore, T., Dudenhöffer‐Pfeifer, M., Fitipaldi, H., Huang, C., Kanbour, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2929263/v1 · Cited by 5
Deguchi, S., Ogata, F., Isaka, T., Otake, H., Nakazawa, Y., Kawasaki, N., & Nagai, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030375 · Cited by 4
“Epidemiologic studies suggest significant associations between the enhanced risk of cardiovascular events and elevated PG levels [8,9] and elevated PG levels 2 h after a meal are associated with an enhanced risk of mortality [2].”
BackgroundMoore, J. M., Vinoskey, C., Salmons, H., Hooshmand, S., & Kressler, J. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100200 · Cited by 4
Bravo-García, A. P., Radford, B. E., Hall, R. C., Broome, S. C., Tee, N., Arthur, B., Janssens, K., Johnston, R. D., Halson, S. L., Devlin, B. L., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112081 · Cited by 12
“Besides fasting glucose and HbA 1c , the 2-h post-prandial blood glucose is an indicator of blood glucose control and an independent risk factor for cardiovascular disease in people with and without type 2 diabetes mellitus [37 – 39].”
Wang, S., Song, S., Gao, J., Wu, W., Fu, Y., Yuan, T., & Zhao, W. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.09.023 · Cited by 8
An α-glucosidase inhibitor could reduce T-wave alternans in type 2 diabetes patients
Eguchi, K., Komori, T., Saito, T., Hoshide, S., & Kario, K. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.08.016 · Cited by 4
Pascual, E. L., Pérez, C. T., Muñoz‐Garach, A., & Ampudia‐Blasco, F. J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.06.007 · Cited by 4
Li, Z., Hu, Y., & Ma, J. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.10.03 · Cited by 7
“[6] Cavalot F, Pagliarino A, Valle M, et al.”
BackgroundZhao, W., Liu, Z., Fan, Z., Wu, Y., Lou, X., Liu, A., & Lu, X. (2023) · European Journal of Nutrition · doi:10.1007/s00394-022-03079-4 · Cited by 6
“Postprandial hyperglycemia is associated with oxidative stress, inflammation, cognitive and vascular function [1, 2], as well as increased risk of type 2 diabetes, some certain cancers, cardiovascular disease and all-cause mortality [3, 4] even in healthy subjects [5].”
BackgroundCauwenberg, J. V., Dunstan, D. W., Cerin, E., Koohsari, M. J., Sugiyama, T., & Owen, N. G. (2019) · Health & Place · doi:10.1016/j.healthplace.2019.02.006 · Cited by 5
Bhoite, R. (2020) · Journal of Diabetes & Metabolism · doi:10.35248/2155-6156.20.11.841 · Cited by 4
“Abnormal glucose metabolism is often a precursor to T2DM or an independent risk factor for atherosclerosis and CVD [3-5,16].”
BackgroundDapagliflozin combination therapy in type 2 diabetes mellitus
Yacoub, T. G. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1111119 · Cited by 6
Management of postprandial glucose: Recommended targets and treatment with biphasic insulin
Liebl, A. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.06.002 · Cited by 5
Williams, D. M., Shrikrishnapalasuriyar, N., Syed, W., Yin, W. L., Chudleigh, R. A., Bain, S. C., Price, D. E., & Stephens, J. W. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.029 · Cited by 4
“The addition of prandial insulin aims to address the worsening PPG levels which are associated with worse cardiovascular outcomes and all-cause mortality (5), and are frequently seen as the first sign of progressive β-cell failure (3).”
BackgroundPredictors of post prandial glucose level in diabetic elderly
Sari, N. P. W. P., & Manungkalit, M. (2019) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v8i2.19022 · Cited by 5
“In DM, especially type 2, the measurement of PPG level could predict cardiovascular events and all-cause mortality [42].”
BackgroundAhmad, A., Lim, L., Morieri, M. L., Tam, C. H. T., Cheng, F., Chikowore, T., Dudenhöffer‐Pfeifer, M., Fitipaldi, H., Huang, C., Kanbour, S., et al. (2023) · medRxiv · doi:10.1101/2023.04.26.23289177 · Cited by 4
Giosuè, A., Skantze, V., Testa, R., D’Abbronzo, G., Costabile, G., Vitale, M., Corrado, A., Jirstrand, M., Landberg, R., Riccardi, G., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156626 · Cited by 184
Kieu, A., Govender, R. D., Östlundh, L., & King, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050027 · Cited by 3
Venn, B. H. B. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000456 · Cited by 4
Metabolic perturbations of post-load hyperglycemia vs. fasting hyperglycemia
Lu, J., Peng, J., Ma, X., Zhang, Y., Zhu, W. M., He, X., Ying, L., Bao, Y., Zhou, J., & Jia, W. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0018-6 · Cited by 3
“[5] followed 505 diabetes patients for 14 years and observed that blood glucose 2 h after lunch, but not fasting blood glucose, was a significant predictor of cardiovascular events.”
BackgroundCutruzzolà, A., Parise, M., Fiorentino, R., Romano, A., Molinaro, V., Gnasso, A., Molfetta, S. D., & Irace, C. (2022) · Nutrients · doi:10.3390/nu14163316 · Cited by 4
Chan, W. B., Luk, A. O. Y., Chow, W. S., & Yeung, M. W. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12515 · Cited by 4
Veloso, A. G., Siersma, V., Heldgaard, P. E., & Olivarius, N. D. F. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2012.09.001 · Cited by 3
Objectifs du contrôle de la glycémie
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.036 · Cited by 4
SKOLNIK, N., Dupree, R. S., & Johnson, E. L. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1359518 · Cited by 3
Moore, J. M., Kressler, J., & Buono, M. J. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102280 · Cited by 3
Diabetes type 2: conventional, social and some genetic predictors of cardiovascular death
Rymar, O. D., Щербакова, Л. В., Олеговна, Щ. А., Mustafina, S. V., Симонова, Г. И., Bakhareva, Y. S., Avdeeva, E. M., Sazonova, O. V., Maksimov, V. N., & Malyutina, S. K. (2021) · Ateroscleroz · doi:10.52727/2078-256x-2021-17-2-39-50 · Cited by 3
Ho, C., Yu, H., Wang, C., Jaw, F., Hsieh, J., Liao, W.-C., Pu, Y., & Liu, S. (2013) · PLoS ONE · doi:10.1371/annotation/c226aa64-8d3b-4c29-971b-84f87b618291 · Cited by 4
Radhamani, R., & Diwakar, S. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1805160 · Cited by 3
“Predictor for cardiovascular events and death in Type II Diabetes (47, 51) Hemoglobin A1C (HbA1c) High blood glucose levels predict a greater risk of CVD in people with or without diabetes (50).”
InfluentialAGP und Ernährung – Mit CGM postprandiale Glukoseverläufe analysieren
Kroeger, J., Siegmund, T., Schubert, O., Keuthage, W., Lettmann, M., Richert, K., & Pfeiffer, A. F. H. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1310-2736 · Cited by 2
“[86] Cavalot F, Pagliarino A, Valle M et al.”
BackgroundHIGH BLOOD GLUCOSE LEVEL INCREASE CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES MELLITUS
Marchelia, L. Z., Purwati, P., & Wironegoro, R. (2017) · Folia Medica Indonesiana · doi:10.20473/fmi.v52i2.5228 · Cited by 2
Takahara, M., Shiraiwa, T., Katakami, N., Matsuoka, T., & Shimomura, I. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0075 · Cited by 2
Park, M., Kang, J., & Han, J.-S. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0293-7 · Cited by 2
Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus
Hu, H., Lei, Y., Yin, L., & Luo, X. (2020) · Medicine · doi:10.1097/md.0000000000022735 · Cited by 4
Addressing Overbasalization to Achieve Glycemic Targets
Cowart, K., Franks, R. B., Pane, O., Murphy, E., & Oldziej, K. (2022) · ADCES in Practice · doi:10.1177/2633559x211068884 · Cited by 2
A single bout of exercise and postprandial hyperglycemia caused by high-fat diet
Numao, S. (2016) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.5.181 · Cited by 3
Tinahones, F. J., Molina‐Vega, M., Parra-Barona, J., Roux, J. A. F., & Gómez‐Huelgas, R. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0452-8 · Cited by 2
WITHDRAWN: Targets for Glycemic Control
Imran, S. A., RABASA-LHORET, R. P. R., & Ross, S. A. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.04.008 · Cited by 4
RetractedPathogenesis of Macrovascular Complications in Diabetes
Gray, S. P., Marco, E. D., Candido, R., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch41 · Cited by 2
Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic controlPreprint
Sebo, Z. L., Chakrabarty, R. P., Grant, R. A., D’Alessandro, K. B., Koss, A. R., Blum, J. L. E., Davidson, S. M., Reczek, C. R., & Chandel, N. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.678294 · Cited by 2
“Postprandial glucose, which is elevated in type II diabetes, is a stronger predictor of cardiovascular disease and all-cause mortality than fasting glucose 34,35 .”
Carrillo‐Arango, H. A., Atencio‐Osorio, M. A., Ordoñez‐Mora, L. T., Benitez‐Gómez, B., Ramírez‐Vélez, R., & Izquierdo, M. (2026) · Experimental Physiology · doi:10.1113/ep093162 · Cited by 1
“Notably,elevated2hpostprandial glucose levels have been associated with a 50% greater risk of cardio-vascular events and an 89% increase in all-cause mortality (Cavalot et al., 2011).”
Mora‐Rodríguez, R., Moreno‐Cabañas, A., Álvarez-Jiménez, L., Mora‐Gonzalez, D., & Morales‐Palomo, F. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003625 · Cited by 3
Xue, X., Li, J., Zheng, W., Zhang, B., Wang, S., Zhang, J., & Yang, Z. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70130 · Cited by 2
“13,14,16 These findings suggest that some patients (e.g., those with isolated FPG elevation) may derive little benefit from glucose-lowering drug treatment in terms of preventing diabetic complications as their baseline risk is low in the first place.”
Block, C. E. M. D., Benamar, M., Fu, A., Maltesen, R., & Giorgino, F. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103985 · Cited by 1
Ateko, R. O., Decker, A., Nyarko, E. N. Y., Kumahor, E. K., Thomford, N. E., Adjei, A. B., Kumi, J., Adadey, S. M., Atiase, Y., & Asare‐Anane, H. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02213-0 · Cited by 1
“Therefore, elevated fasting glucose reflects relatively advanced metabolic dysfunction, although it may be less sensitive in detecting early dysglycaemia [6, 28, 60].”
Personalisierte Diäten versprechen mehr Erfolg
Simon, M. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0794-3 · Cited by 1
Baud, G., Caiazzo, R. J., Verkindt, H., Nesslany, P., Torres, F., Raverdy, V., & Pattou, F. N. (2017) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2017.10.001 · Cited by 1
Contrôle de la glycémie post-prandiale : apport des nouvelles formulations d’insuline ultra-rapides
Reznik, Y., & Jubin, L. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.09.004 · Cited by 1
Голубев, С. А. (2025) · Рецепт · doi:10.34883/pi.2025.28.5.003 · Cited by 1
The Importance of Postprandial Hyperglycemia Position Statement of the Danube Mco Experts
Barkai, L., Hâncu, N., Jermendy, G., Konstantinova, M., Lichiardopol, R., Moța, M., Tankova, T. I., Temelkova, N., & Winkler, G. (2015) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2015-0011 · Cited by 1
“These data have been confirmed in a longer follow-up [12].”
ResultIhana‐Sugiyama, N., Yamamoto‐Honda, R., Sugiyama, T., Tsujimoto, T., Kakei, M., & Noda, M. (2017) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.902218 · Cited by 1
Shi, C., Sun, L., Bai, R., Wang, H., Liu, D., & Du, J. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1558853 · Cited by 1
Kualitas diet dan kontrol glikemik pada orang dewasa dengan diabetes melitus tipe dua
Briawan, D., Heryanda, M. F., & Sudikno, S. (2021) · Jurnal Gizi Klinik Indonesia · doi:10.22146/ijcn.62815 · Cited by 7
“Bahkan, jika kadar GD2PP lebih dari atau sama dengan 181 mg/dL dapat meningkatkan kejadian kardiovaskular 1,46 kali lebih tinggi dan menjadi penyebab kematian 1,86 kali lebih tinggi pada DMT2 [33].”
BackgroundPathogenesis of Macrovascular Complications in Diabetes
Østergaard, J. A., Block, T. J., Dahm, S. I., Khan, W., & Jandeleit-Dahm, K. A. M. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch46 · Cited by 1
Exercise and Glycemic Control in Individuals with Type 2 Diabetes
Oberlin, D. J. (2011) · MOspace Institutional Repository (University of Missouri) · Cited by 1
Ahmed, S. S. (2015) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20150304.13
New developments to optimize postprandial glucose control with insulin in patients with diabetes
de Galan, B. E. (2012) · Diabetes Management · doi:10.2217/dmt.12.20
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Harno, K., Satman, İ., & Vergès, B. L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814534366
“A 14-year follow up of more than 500 patients with type 2 diabetes found 2-hour blood glucose levels but not FPG to predict cardiovascular events and all-cause mortality.(47) The role of SMBG in type 2 diabetes is also supported by the growing evidence for the association between glycemic variability and an increased…”
BackgroundThe Role of Grapefruit Consumption in Cardiometabolic Health in Overweight and Obese Adults
Dow, C. A. (2013) · UA Campus Repository (The University of Arizona)
Diabetes in China 3 Early therapy for type 2 diabetes in China
Yang, W., & Key, G. P. (2014)
Yoon, J., Shin, D.-W., Kim, J., Lee, K. B., Roh, H., & Ahn, M. (2015) · Journal of Neurocritical Care · doi:10.18700/jnc.2015.8.2.91
HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A
Cheng, D., Yang, F., Liu, Y., Li, J., Qin, X. Y., Wang, X., & Wang, N. (2014)
Short-term aerobic exercise training in type 2 diabetes
Kearney, M. L. (2015) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/50150
Oberlin, D. J. (2016) · ProQuest Demo Repository · Cited by 1
Martin, K. (2017) · Otago University Research Archive (University of Otago) · Cited by 2
Rozier, E. W. D. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217809
Rees, J. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3tq5rt66
Lifestyle intervention strategies for diabetes management
Tay, J., & Tay, J. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.25909/5b63b9ac0685f
Prävention und Therapie von Adipositas durch Personalisierung der Ernährung
Schröder, T., & Sina, C. (2019) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-0962-3295
“[17] Cavalot F, Pagliarino A, Valle M et al.”
BackgroundRoy, S., Biswas, C., Bera, M., & Bhattacharya, G. (2020) · Clinical Diabetology · doi:10.5603/dk.2019.0027
“Postprandial spikes in blood sugar, along with episodes of hypoglycemia, are responsible for an alarming increase in cardiovascular events in DM [2].”
BackgroundBurbano, J., & Sanchez, L. D. (2020) · doi:10.11565/arsmed.v45i1.1600
Glucose control, cardiorespiratory fitness, and dietary composition in healthy men.
Moller, J. C. (2020) · SUNScholar (Stellenbosch University) · Cited by 1
Kreß, S., Borck, A., Zisman, A., Bramlage, P., & Siegmund, T. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s267882
Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
Gonzales, K. M., & Smith, S. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch8
Alsaedi, Z. A., Alahmadi, K. M., Khan, A. Z., Alrait, E. M., Ghamdi, M. K. A., Alqahtani, A. M., Alkahmous, H. A., Alanazi, R. S., Aljohani, A. A., & Alsawyan, W. A. (2021) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/acxdc9hqpc
Wada, M., Torigoe, K., Yoshinaga, Y., Miyazaki, M., Kayoko, S. E. T. O., & MATSUMOTO, Y. (2022) · Japanese Journal of Complementary and Alternative Medicine · doi:10.1625/jcam.19.51
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_8
Postprandiale Blutzuckerwerte und kardiovaskuläres Risiko im Fokus
(2012) · Info Diabetologie · doi:10.1007/s15034-012-0037-1
Postprandiale Blutzuckerwerte und kardiovaskuläres Risiko im Fokus
(2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0199-8
Hinweise auf besseren kardiovaskulären Schutz des Diabetikers
RED (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0357-z
Hinweise auf besseren kardiovaskulären Schutz des Diabetikers
RED (2012) · CardioVasc · doi:10.1007/s15027-012-0176-2
Brown, J. E., Burden, H. J., Pham, T., & Braakhuis, A. J. (2022) · Research Square · doi:10.21203/rs.3.rs-2219674/v1
Metadata
- Authors
- Cavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., & Trovati, M.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga Faculty of Medicine of Turin University, San Luigi Gonzaga Hospital, Turin, Italy
- Corresponding author
- Trovati, Mariella
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2237-2243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177732
- OpenAlex
- W2079118015
- Cited by
- 322
- References
- 25
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 24 · 2021: 21 · 2020: 25 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 32 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 17
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, postprandial blood glucose, cardiovascular events, all-cause mortality, HbA1c, glycemic control, cardiovascular risk factors, long-term prognosis
- MeSH terms
- Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Male, Middle Aged, Proportional Hazards Models, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.